skip to content »

Center for Cell and Gene Therapy

Houston, Texas

Center for Cell and Gene Therapy
Center for Cell and Gene Therapy
not shown on screen

Reconstituting Immunity Post Transplant

H26374; Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes for the Prophylaxis and Treatment of EBV CMV, and adenovirus Infection post Allogeneic Stem Cell Transplant (VIRAGE): This study uses autologous EBV, CMV, and adenovirus specific T-Lymphocytes to prevent and treat viral infections following allogeneic stem cell transplants. Compared to some of our other similar studies, the cells used in this study are generated in the laboratory using a faster and simpler technique.

H29966; ADMINISTRATION OF RAPIDLY GENERATED MULTIVIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR THE PROPHYLAXIS AND TREATMENT OF EBV, CMV, ADENOVIRUS, HHV6, AND BK VIRUS INFECTIONS POST ALLOGENEIC STEM CELL TRANSPLANT (ARMS): This study uses autologous EBV, CMV, adenovirus, HHV6 and BK virus specific T-Lymphocytes to prevent and treat viral infections following allogeneic stem cell transplants. Compared to some of our other similar studies, the cells used in this study are generated in the laboratory using a faster and simpler technique.

E-mail this page to a friend